Slit2 promotes tumor growth and invasion in chemically induced skin carcinogenesis.
Slit, a neuronal guidance cue, binds to Roundabout (Robo) receptors to modulate neuronal, leukocytic, and endothelial migration. Slit has been reported to have an important effect on tumor growth and metastasis. In the current study, we evaluated the role of Slit2 in skin tumor growth and invasion in mice using a two-step chemical carcinogenesis protocol. We found that Slit2 expression correlated with the loss of basement membrane in the samples of human skin squamous cell carcinoma at different stages of disease progression. Slit2-Tg mice developed significantly more skin tumors than wild-type mice. Furthermore, the skin tumors that occurred in Slit2-Tg mice were significantly larger than those in the wild-type mice 10 weeks after 7,12-dimethylbenz[a]anthracene initiation until the end of the experiment. We also found that pathological development of the wild-type mice was delayed compared with that of Slit2-Tg mice. To further investigate the mechanism of increasing tumors in Slit2-Tg mice, we analyzed the expression of 5-bromo-2'-deoxyuridine (BrdU) in mouse skin lesions and found that the number of BrdU-positive cells and microvessel density in skin lesions were significantly higher in Slit2-Tg mice than in wild-type mice. Histological staining of PAS and type IV collagen and the colocalization of Slit2 and type IV collagen demonstrated varying degrees of loss of the basement membrane in the skin lesions from Slit2-Tg mice that were at the stage of carcinoma in situ. However, the basement membrane was well defined in the wild-type mice. In addition, MMP2, but not MMP9, was upregulated in the skin tissue of Slit2-Tg mice. Interruption of Slit2-Robo1 signaling by the antibody R5 significantly repressed the invasive capability of the squamous cell carcinoma cell line A431. Taken together, our findings reveal that Slit2 promotes DMBA/TPA-induced skin tumorigenesis by increasing cell proliferation, microvessel density, and invasive behavior of cutaneous squamous cell carcinoma, along with loss of basement membrane, by upregulation of MMP2 expression.
Vascular Biology Research Institute, Guangdong Pharmaceutical University, Guangzhou, China.
Cuiling
C
Qi
Dermatological Department, NanFang Hospital, Guangzhou, China.
Haimei
H
Lan
Vascular Biology Research Institute, Guangdong Pharmaceutical University, Guangzhou, China.
Jie
J
Ye
Vascular Biology Research Institute, Guangdong Pharmaceutical University, Guangzhou, China.
Weidong
W
Li
Vascular Biology Research Institute, Guangdong Pharmaceutical University, Guangzhou, China.
Ping
P
Wei
Vascular Biology Research Institute, Guangdong Pharmaceutical University, Guangzhou, China.
Yang
Y
Yang
Vascular Biology Research Institute, Guangdong Pharmaceutical University, Guangzhou, China.
Simei
S
Guo
Vascular Biology Research Institute, Guangdong Pharmaceutical University, Guangzhou, China.
Tian
T
Lan
Vascular Biology Research Institute, Guangdong Pharmaceutical University, Guangzhou, China.
Jiangchao
J
Li
Vascular Biology Research Institute, Guangdong Pharmaceutical University, Guangzhou, China.
Qianqian
Q
Zhang
Vascular Biology Research Institute, Guangdong Pharmaceutical University, Guangzhou, China.
Xiaodong
X
He
Vascular Biology Research Institute, Guangdong Pharmaceutical University, Guangzhou, China.
Lijing
L
Wang
D015127:9,10-Dimethyl-1,2-benzanthracene; D000818:Animals; D001485:Basement Membrane / Q000378:metabolism / Q000473:pathology; D001808:Blood Vessels / Q000378:metabolism / Q000473:pathology; D001973:Bromodeoxyuridine / Q000378:metabolism; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced / Q000235:genetics / Q000378:metabolism*; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D024141:Collagen Type IV / Q000378:metabolism; D006801:Humans; D007150:Immunohistochemistry; D036341:Intercellular Signaling Peptides and Proteins / Q000235:genetics / Q000378:metabolism*; D020778:Matrix Metalloproteinase 2 / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D018613:Microscopy, Confocal; D009361:Neoplasm Invasiveness; D009419:Nerve Tissue Proteins / Q000235:genetics / Q000378:metabolism*; D012867:Skin / Q000098:blood supply / Q000378:metabolism / Q000473:pathology; D012878:Skin Neoplasms / Q000139:chemically induced / Q000235:genetics / Q000378:metabolism*; D013755:Tetradecanoylphorbol Acetate; D047368:Tumor Burden; D000098552:Slit Homolog 2 Protein
D024141:Collagen Type IV; D036341:Intercellular Signaling Peptides and Proteins; D009419:Nerve Tissue Proteins; D015127:9,10-Dimethyl-1,2-benzanthracene; D020778:Matrix Metalloproteinase 2; D001973:Bromodeoxyuridine; D013755:Tetradecanoylphorbol Acetate; D000098552:Slit Homolog 2 Protein